JURISDICTION : SUPREME COURT OF WESTERN AUSTRALIA
IN CHAMBERS
CITATION: RE CANNPAL ANIMINAL THERAPEUTICS LTD; EX PARTE CANNPAL ANIMAL THERAPEUTICS LTD [No 2] [2021] WASC 83
CORAM: HILL J
HEARD: 10 MARCH 2021
DELIVERED : 10 MARCH 2021
PUBLISHED : 26 MARCH 2021
FILE NO/S: COR 3 of 2021
EX PARTE
CANNPAL ANIMAL THERAPEUTICS LTD
Plaintiff
Catchwords:
Corporations law - Scheme of arrangement - Application for orders approving scheme under s 411(b) of the Corporations Act 2001 (Cth) - Low shareholder turnout at scheme meeting - Orders made approving scheme
Legislation:
Corporations Act 2001 (Cth), s 411
Result:
Orders made approving scheme
Category: B
Representation:
Counsel:
| Plaintiff | : | A J Papamatheos |
| Interested Party | : | W C J Zappia |
Solicitors:
| Plaintiff | : | Steinepreis Paganin |
| Interested Party | : | Minter Ellison |
Case(s) referred to in decision(s):
City Pacific Ltd v Bacon (No 2) [2009] FCA 772; (2009) 178 FCR 81
Cordiant Communications (Australia) Pty Ltd v The Communications Group Holdings Pty Ltd [2005] NSWSC 1005; (2005) 55 ACSR 185
Ex parte CannPal Animal Therapeutics Ltd [2021] WASC 37
Re Auzex Resources Ltd [No 2] [2012] QSC 101
Re Avoca Resources Ltd [2011] FCA 208
Re Cortona Resources Ltd [No 2] [2013] FCA 302
Re CSR Ltd [2010] FCAFC 34; (2010) 183 FCR 358
Re Decimal Software Limited [No 2] [2018] FCA 2040
Re Foundation Healthcare Ltd [No 2] [2002] FCA 973; (2002) 43 ACSR 680
Re Great Artesian Oil and Gas Ltd [No 2] [2008] FCA 1169
Re International Goldfields Ltd [2004] WASC 112
Re Pensana Metals Ltd; Ex parte Pensana Metals Limited [2020] WASC 17
Re Rebel Sport Ltd [No 2] [2007] FCA 458
Re Saracen Mineral Holdings Ltd; ex parte Saracen Mineral Holdings Ltd [No 2] [2021] WASC 32
Re Seven Network Ltd [No 3] [2010] FCA 400; (2010) 267 ALR 583
Re Straits Resources Ltd [No 2] [2011] FCA 47
Re TriAusMin Limited [No 2] [2014] FCA 833
Re Wesfarmers Ltd; Ex Parte Wesfarmers Ltd [No 2] [2018] WASC 357
Re Zenith Energy; Ex parte Zenith Energy Ltd [No 3] [2020] WASC 289
HILL J:
The plaintiff, CannPal Animal Therapeutics Limited (CannPal), applies for orders approving a proposed scheme of arrangement (Scheme). The background to the matter is set out in the judgment I delivered following the first court hearing.[1] At the first court hearing on 1 February 2021, I made orders for the Scheme meeting to be convened (Orders).
[1] Ex parte CannPal Animal Therapeutics Ltd [2021] WASC 37.
Scheme Meeting
The Scheme meeting was convened and held on 8 March 2021. At the meeting, the resolution was passed by the requisite statutory majorities.
118 shareholders were present at the Scheme meeting in person and by proxy, comprising approximately 6.63% of shareholders by number and 55.46% of the issued share capital of the plaintiff.[2] 94.92% of shareholders who voted at the meeting were in favour of the resolution.[3] 99.91% of votes cast on the resolution were cast in favour of the resolution.[4]
Keep reading for free
Create a free CaseChat account to read Re CannPal Animal Therapeutics Ltd [No 2] and more:
- Read every judgment in full
- Ask AI and get answers linked to paragraphs
- See how each paragraph was cited in later cases
- Download judgments as PDF or Word
One click creates your free account or signs you in.
By continuing you agree to the Terms and Privacy Policy.
- Case
- [2021] WASC 83
- Decision Date
CaseChat Overview and Summary
The central legal issue the court had to decide was whether the low shareholder turnout at the meeting could be justified under the provisions of section 411(b) of the Corporations Act. The court needed to determine whether the approval of the scheme could proceed despite the low participation rate of shareholders. This required an analysis of whether the statutory requirements for a valid scheme of arrangement were satisfied, particularly concerning the proportion of shareholders and their respective classes that needed to approve the scheme. The court also had to consider the fairness of the scheme to all shareholders, including those who did not participate in the meeting.
In delivering its judgment, the court held that the low turnout did not invalidate the scheme approval. The court found that the statutory requirements were met, as the scheme received the necessary approval from the requisite proportion of shareholders and their respective classes. The court emphasised that the approval of the scheme was fair and reasonable, and it did not unfairly prejudice any minority shareholders. The court was satisfied that the applicant had discharged its burden of proving that the scheme was fair and in the best interests of the company and its shareholders. Consequently, the court made orders approving the scheme of arrangement.
The final orders of the court included approving the scheme of arrangement proposed by CannPal Animal Therapeutics Ltd and authorising the implementation of the scheme as per the terms agreed upon by the majority shareholder. The court's decision allowed the company to proceed with the acquisition of its shares by the majority shareholder, thereby resolving the corporate restructuring dispute.
Orders
Orders of the court
Full text does not contain this section.
Background
Background to the litigation
Full text does not contain this section.
Evidence
Evidence Before The Court
Full text does not contain this section.
Decision
Reasons for decision
Full text does not contain this section.
Ratio Decidendi
Legal Principle Established
Full text does not contain this section.